SCHEMBL25233252

SCHEMBL25233252

O=S(=O)(NCc1nn(-c2ccc(C(F)(F)F)cc2)c2ccccc12)C1CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA2 P42262 1/20 0.49
▸ NPY5R Q15761 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SYK P43405 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ SCN9A Q15858 2/20 0.37
▸ SCN5A Q14524 1/20 0.37
▸ NR1D1 P20393 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ CCR1 P32246 2/20 0.37
▸ TEAD1 P28347 1/20 0.37
▸ TEAD4 Q15561 1/20 0.37
▸ TEAD2 Q15562 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30469111 1.00 GRIA2 (0.49) GRIA2NPY5RKDM4ENPSR1SYK
SCHEMBL25281888 0.84 GRIA2 (0.45) GRIA2NPY5RKDM4ENPSR1SYK
SCHEMBL30469100 0.84 GRIA2 (0.45) GRIA2NPY5RKDM4ENPSR1SYK
SCHEMBL25230406 0.83 NPY5R (0.41) GRIA2NPY5RKDM4ENPSR1SYK
SCHEMBL25278984 0.82 TEAD1 (0.43) NPY5RKDM4ENPSR1SYKLMNA
SCHEMBL25275654 0.80 NPY5R (0.39) NPY5RKDM4ENPSR1SYKLMNA
SCHEMBL30469123 0.78 NPY5R (0.48) NPY5RLMNAPOLB
SCHEMBL25274819 0.78 NPY5R (0.48) NPY5RLMNAPOLB
SCHEMBL25281431 0.78 NPY5R (0.44) NPY5RPTGS2LMNAPOLBSCN9A
SCHEMBL30469156 0.78 NPY5R (0.44) NPY5RPTGS2LMNAPOLBSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122782-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 — — WO disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 GRIA2 3796/4885NPY5R 2669/4885KDM4E 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback